Li Kang-hua, Lin Zhang-yuan, Lei Guang-hua
Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008, China.
Hunan Yi Ke Da Xue Xue Bao. 2003 Aug;28(4):395-7.
To evaluate the clinical outcome of ZEPHIR plate in treating cervical spondylotic myelopathy(CSM).
We retrospectively analyzed 18 patients undergoing anterior decompression fusion and internal fixation with ZEPHIR plate. Follow-up period ranged from 3 to 12 months (an average of 9 months). The bone graft fusion rate, rehabilitation of neurological deficits, and the complications of the hardware were observed. We assessed the clinical effect with JOA score.
Rehabilitation of neurological deficits were observed in 16 patients, The JOA score after the operation significantly increased than before the operation. The fusion rate was 100%, the intervertebral height were maintained, and no complications related to the plate were found.
ZEPHIR plate in the treatment of cervical spondylotic myelopathy may increase the fusion rate of the bone graft significantly with low incidence of complication.
评估ZEPHIR钢板治疗脊髓型颈椎病（CSM）的临床疗效。
回顾性分析18例行前路减压融合并用ZEPHIR钢板内固定的患者。随访时间为3至12个月（平均9个月）。观察植骨融合率、神经功能缺损的恢复情况及内固定器械的并发症。采用JOA评分评估临床疗效。
16例患者神经功能缺损得到恢复，术后JOA评分较术前显著提高。融合率为100%，椎间隙高度得以维持，未发现与钢板相关的并发症。
ZEPHIR钢板治疗脊髓型颈椎病可显著提高植骨融合率，并发症发生率低。
